INDIVIDUALIZATION OF THERAPY WITH ANTIVIRAL AGENTS

Details for Australian Patent Application No. 2002349225 (hide)

Owner XANTHUS LIFE SCIENCES, INC.

Inventors LEYLAND-JONES, Brian

Pub. Number AU-A-2002349225

PCT Number PCT/CA02/01824

PCT Pub. Number WO2003/046559

Priority 60/333,500 28.11.01 US

Filing date 27 November 2002

Wipo publication date 10 June 2003

International Classifications

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 60/333,500 28.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002349225

12 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002349226-LACTIC ACID BACTERIA AND THEIR USE FOR TREATING AND PREVENTING CANCER

2002349224-MAGNESIUM-BASED CASTING ALLOYS HAVING IMPROVED ELEVATED TEMPERATURE PERFORMANCE, OXYDATION-RESISTANT MAGNESIUM ALLOY MELTS, MAGNESIUM-BASED ALLOY CASTINGS PREPARED THEREFROM AND METHODS FOR PREPARING SAME